InspectIR COVID-19 Breathalyzer: FDA authorizes first breath test for Covid

ForumIAS announcing GS Foundation Program for UPSC CSE 2025-26 from 19 April. Click Here for more information.

ForumIAS Answer Writing Focus Group (AWFG) for Mains 2024 commencing from 24th June 2024. The Entrance Test for the program will be held on 28th April 2024 at 9 AM. To know more about the program visit: https://forumias.com/blog/awfg2024

What is the News?

The US Food and Drug Administration has issued an emergency use authorization for the Covid-19 test named InspectIR COVID-19 Breathalyzer.

What is InspectIR COVID-19 Breathalyzer?

It is the first testing device that can detect COVID-19 in the breath samples of humans.

How does the test device work?

The device uses a technique called gas chromatography gas mass-spectrometry (GC-MS) to separate and identify chemical mixtures and rapidly detect five Volatile Organic Compounds (VOCs) associated with SARS-CoV-2 infection in exhaled breath. 

When the device detects the presence of VOC markers of SARS-CoV-2, a presumptive (unconfirmed) positive test result is returned and should be confirmed with a molecular test.

Significance of this device

Firstly, this device is about the size of a piece of carry-on luggage and can be used in doctor’s offices, hospitals and mobile testing sites.

Secondly, the device can provide results in less than three minutes.

source: This post is based on the article “FDA authorizes first breath test for Covid” published in The Hindu on 16th April 2022.

Print Friendly and PDF
Blog
Academy
Community